#64 Incidence of overactive bladder after robot-assisted laparoscopic radical prostatectomy and assessment of the associated risk factors

Presenter: Takashi Hamakawa

#65 Comparisons of clinical outcomes between novel tailored transvaginal mesh surgery and vaginal native tissue repair surgery for pelvic organ prolapse

Presenter: Ting-Chen Chang

#66 Mode of delivery and levator hiatal area

Presenter: Katalin Bertalan

#67 CORRELATION BETWEEN PELVIC FLOOR MUSCLE STRENGTH AND VAGINAL TROPHISM IN CONTINENT WOMEN

Presenter: João Amaro

#68 Risk factors for coexistence of cervical elongation in uterine prolapse

Presenter: Sheng-Mou Hsiao

#69 Laparoscopic cervico- (CESA) and vagino-sacropexy (VASA) as treatment for female pelvic organ prolapse

Presenter: Sebastian Ludwig

#70 PERCUTANEOUS TIBIAL NERVE STIMULATION IN THE TREATMENT OF REFRACTORY PAINFUL BLADDER SYNDROME ∕ INTERSTITIAL CYSTITIS

Presenter: Mohamed Rasheed

#71 EVOLUTION OF URINARY INCONTINENCE AFTER PELVIC ORGAN PROLAPSE SURGERY: INFLUENCE OF SURGICAL APPROACH AND IMPLEMENTATION OF SUBURETHRAL SLING.

Presenter: Luis López-Fando Lavalle

#72 Extracorporeal magnetic innervation increases functional bladder capacity and quality of life in patients with urinary incontinence after robotic-assisted radical prostatectomy

Presenter: Po-chih Chang

#73 The Long-Term Effect of a Special Programme of Pelvic Floor Muscle Training for Female Patients with LUTS in Japan

Presenter: Tamami Taniguchi

#74 Febrile urinary tract infection onset during intermittent catheterization: what is the risk factor?

Presenter: Masaaki Imamura

#75 VALIDATION OF TREATMENT WITH SEDATIVE MEDIUM FREQUENCY ELECTROTHERAPY FOR OAB, UUI AND LUTS

Presenter: Cristina Naranjo-Ortiz

#76 The Effect of Aging on Urodynamic Parameters in Women with Stress Urinary Incontinence

Presenter: Jae Hyung You

#77 What are the clinical factors associated with attendance at a multidisciplinary perineal clinic among patients with obstetrical anal sphincter injuries?

Presenter: Annick Poirier

#78 The Effect of Preoperative Waiting Time on the Quality of Life of Urogynaecology Patients

Presenter: Yvonne Leong

#79 Outcomes and Complications of Cystectomy and Urinary Diversion for Benign Indications: A Survival Analysis

Presenter: Yahir Santiago-Lastra

#80 Risk factors for lower urinary tract dysfunction and symptoms after successful renal transplantation

Presenter: Takahiko Mitsui

#81 Telephone Triage Pelvic Floor Assessment Clinic

Presenter: Alexis Schizas

#82 Industry as a stakeholder in the possible implementation and normalisation of a mixed intermittent catheter package in the NHS: the MultICath study

Presenter: Adèle Long

#83 A survey of functional urology teaching in Italy: should the national and international societies further contribute to urologists’ training?

Presenter: Enrico Finazzi Agrò

#84 Single Institution Experience of Over 100 Cases of Augmentation Enterocystoplasty in the Patients with End-stage Bladder Diseases

Presenter: Jia-Fong Jhang

#85 Putting the costs and benefits of Intravesical Cystistat into perspective – comparison to published data for intravesical botox treatment

Presenter: Susan Fowler

#86 Pelvic floor training is not painful in the majority of women shortly after childbirth

Presenter: Alexandra Vermandel

#87 Outcomes of Classification-Based Outpatient Physiotherapy Treatment for Female Urinary Incontinence in Women 65 and Older

Presenter: Cynthia Neville

#89 Influence of a distraction task on the involuntary reflex contraction of the pelvic floor muscles following cough.

Presenter: Xavier Deffieux

#90 Whole body vibration for the pelvic floor muscle training: preliminary trial

Presenter: Simone Botelho

#91 Is the 24 hour pad test an accurate assessment tool for success of continence surgery?

Presenter: Roopali Karmarkar

#92 Development of new nomograms of urinary flow rates in Japanese men

Presenter: Masaki Yoshida

#93 Is the laser mightier than the sword? A comparative study for the urethrotomy

Presenter: Coen Holzhauer

#94 Prostatic arterial embolization in patients with benign prostatic hyperplasia: A systematic review and meta-analysis

Presenter: Won Jin Cho

#95 The prevalence and association of lower urinary tract symptoms in men and visiting hospital: community health survey.

Presenter: Kyu Shik Kim

#96 Clinical Significance of Prostatic-urethral Angulation on the Treatment Outcome of Patients with Symptomatic Benign Prostatic Hyperplasia Treated with Tamsulosin Hydrochloride

Presenter: Abdel Hamid El-Bahnasy

#97 Long term outcomes of the AdVance male transobturator sling for treatment of post-prostatectomy incontinence: impact of radiotherapy and storage dysfunction

Presenter: Giovanni Losco

#98 Prostatic Urethral Angle does not affect the severity of urinary symptom and peak flow rate in men with LUTS/BPH; a multicenter, prospective study

Presenter: Ki Ho Kim

#99 Microscopic hematuria screening in a male consumer population with lower urinary tract symptoms

Presenter: Franklin C Lowe

#100 Prospective observational study of predictive clinical parameters in patients with benign prostatic hypertrophy medicated with silodosin for over one year

Presenter: Yasuhiro Kaiho

#101 Factors Affecting Patient Satisfaction after HoLEP: A Prospective Cohort Study

Presenter: Seung-June Oh

#102 DISEASE-DEPENDENT FACTORS INFLUENCING THE APPEARANCE OF URINARY INCONTINENCE AFTER RADICAL PROSTATECTOMY

Presenter: Bárbara Padilla-Fernández

#103 PATIENT-DEPENDENT FACTORS INFLUENCING THE APPEARANCE OF URINARY INCONTINENCE AFTER RADICAL PROSTATECTOMY

Presenter: Bárbara Padilla-Fernández

#104 First post-void residual urine volume following holmium laser enucleation of the prostate: Predictor of de novo urinary incontinence

Presenter: Jun Hwa Noh

#105 The correlation of aortic calcification and LUTS

Presenter: YoungSeop Chang

#106 TREATMENT OF URETHRAL STRICTURES CURES BOTH OBSTRUCTIVE AND STORAGE VOIDING SYMPTOMS

Presenter: Michael Schulster

#107 Worth it’s Pad Weight in Gold’ – Assessment of the outcomes of surgical management of post prostatectomy incontinence.

Presenter: Maeve Dooher

#108 Long-term Combined α-blockers and 5α–reductase Inhibitor in BPH Therapeutic Effects, Adherence, and Predictors for Withdrawal of Medication

Presenter: Hueih-Ling Ong

#109 Symptomatic differences in non-obstructive patients with poor detrusor function versus normal detrusor function

Presenter: Kevin Rademakers

#110 Evaluation of safety, tolerability and efficacy of TiLoop®, a titanized inside-out transobturatory sling for male stress urinary incontinence

Presenter: Riccardo Bientinesi

#111 ETIOLOGY OF NOCTURIA IN ELDERLY MEN

Presenter: Jonathan Gerber

#112 Correlation of IPSS-Storage Score, OABSS and USS in Patients with OAB and Hypersensitive Bladder – Which One is the Best Score System for Assessing Severity of OAB ?

Presenter: Fei-Chi Chuang

#113 THE INVOLVEMENT OF BLADDER NECK/PELVIC FLOOR ON BLADDER SENSATION AND DETRUSOR OVERACTIVITY DURING BLADDER FILLING IN PATIENTS WITH OAB

Presenter: Stefan De Wachter

#114 Description of patient profile and healthcare resources use in OAB patients treated with flexible dose antimuscarinics

Presenter: Daniel Arumi

#115 CHILDHOOD SEXUAL TRAUMA MORE PREVALENT IN PATIENTS WITH OVERACTIVE BLADDER

Presenter: H Henry Lai

#116 Assessing outcomes in OAB: What is the way of the future?

Presenter: Christopher Chapple

#117 Urine nerve growth factor in patients with Idiopathic detrusor overctivity and in patients with overactive bladder without detrusor overactivity

Presenter: Elena Tur

#118 Characteristics of Patients With Overactive Bladder Who Escalate to a Higher Dose of Antimuscarinic: Efficacy and Safety Outcomes

Presenter: Fady Ntanios

#119 Changes in EMG signals of the pelvic floor in women with the overactive bladder syndrome after biofeedback assisted pelvic floor muscle therapy

Presenter: Jeroen Voorham

#120 Does asymptomatic bacteriuria increases the risk of urosepsis or modifies intra-detrusor botulinum toxin A (BoNTA) efficacy?

Presenter: Xavier Biardeau

#121 SAFETY AND EFFICACY OF BOTULINIUM TOXIN A INTRAVESICAL INSTILLATION IN TREATMENT OF REFRACTORY OVERACTIVE BLADDER

Presenter: Osama Abdallah

#122 Is There an Association Between Vascular Risk Factors and Over Active Bladder ? ： A random cross-sectional epidemiological study

Presenter: Teruhiko Tsuru

#123 Comparison of Long Term Compliance with Mirabegron and Solifenacin in Treatment-naive Female Overactive Bladder Patients

Presenter: Manami Kinjo

#124 Clinical impications of urgency severity in acute uncomplicated cystitis patients treated with antibiotics

Presenter: Hoon Choi

#125 Acupuncture for overactive bladder in female adult: a randomized controlled trial

Presenter: Changxiao He

#126 Are uroflowmetry parameters useful in the overactive bladder diagnosis?

Presenter: Konrad Futyma

#127 The lower urinary tract symptoms are associated with spina bifida occulta in children

Presenter: Shucheng Zhang

#128 technique, interpretation and clinical relevance of urethral pressure variation during filling phase of urodynamic investigation: systematic review of the literature

Presenter: Maxime Kummeling

#129 A new nomogram to noninvasively diagnose Bladder Outlet Obstruction using condom catheter measurements

Presenter: Ron van Mastrigt

#130 Relationship between urinary incontinence symptom diagnosis and urodynamics diagnosis. Is it the time to revisit NICE and recent trials recommendation?

Presenter: Hashim Hashim

#131 APPLICATION OF THE D INDEX: NOMOGRAMS ALLOWING EVALUATION OF BLADDER OUTLET OBSTRUCTION (BOO) IN MEN FROM FREE UROFLOWS (FF)

Presenter: Francoise Valentini

#132 Serum low density lipoprotein cholesterol / high density lipoprotein cholesterol ratio as a predictor of bladder dysfunction

Presenter: Hidenori Akaihata

#133 Urodynamic examinations performed before stress incontinence surgery in female patients: costs’ analysis in Italy

Presenter: Enrico Finazzi Agrò

#134 The relationship between maximum urethral closure pressure and leak point pressure in women with stress urinary incontinence

Presenter: Chiharu Shibata

#135 What size catheters should be used in women during urodynamics?

Presenter: Haitham Abdelmoteleb

#136 What size catheter should be used in men undergoing pressure/flow studies?

Presenter: Haitham Abdelmoteleb